Title: COVID–19 Supply Chain Resiliency Act of 2021
Policy area: Commerce

Summary:
COVID-19 Supply Chain Resiliency Act of 2021
This bill establishes the Office of COVID-19 Supply Chain Resiliency to identify and address supply chain issues related to the COVID-19 (i.e., coronavirus disease 2019) pandemic.
Specifically, the office must establish a national strategy to address identified supply chain issues related to the pandemic, serve as a central point of contact for and provide technical assistance to entities dealing with these issues, and develop legislative recommendations to strengthen critical supply chains for pandemics.
The office shall cease to exist 18 months after the COVID-19 public health emergency (and any renewal thereof) is terminated.

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1024 Introduced in House (IH)]

<DOC>






117th CONGRESS
  1st Session
                                H. R. 1024

 To establish the Office of COVID-19 Supply Chain Resiliency, and for 
                            other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 11, 2021

Mr. Schneider (for himself and Mr. Johnson of South Dakota) introduced 
 the following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
 To establish the Office of COVID-19 Supply Chain Resiliency, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``COVID-19 Supply Chain Resiliency Act 
of 2021''.

SEC. 2. OFFICE OF COVID-19 SUPPLY CHAIN RESILIENCY.

    (a) Establishment of Office.--There is established in the Executive 
Office of the President the Office of COVID-19 Supply Chain Resiliency 
(in this section referred to as ``the Office'').
    (b) Director.--
            (1) In general.--There shall be at the head of the Office a 
        Director who shall be appointed by the President.
            (2) Appointment of first director.--Not later than 30 days 
        after the date of the enactment of this Act, the President 
        shall appoint an individual to serve as the Director.
            (3) Vacancy.--A vacancy in the position of Director shall 
        be filled not later than 60 days after the date on which the 
        vacancy occurs and shall be filled in the same manner in which 
        the original appointment was made.
    (c) Deputy Directors.--
            (1) Types of deputy directors.--To assist the Director in 
        carrying out the functions of this Act, the Director shall 
        appoint Deputy Directors as follows:
                    (A) The Deputy Director for the Medical Supply 
                Chain.
                    (B) The Deputy Director for the Food Supply Chain.
                    (C) The Deputy Director for the Industrial Supply 
                Chain.
                    (D) The Deputy Director for Interagency 
                Coordination.
            (2) Additional deputy directors.--The Director may appoint 
        additional Deputy Directors as the Director determines 
        necessary.
    (d) Functions.--The functions of the Office are to--
            (1) identify supply chain issues related the COVID-19 
        pandemic;
            (2) not later than 60 days after the establishment of the 
        Office, establish a national strategy to address such supply 
        chain issues, in consultation with--
                    (A) the heads of other agencies of the Federal 
                Government, including--
                            (i) the Secretary of Agriculture;
                            (ii) the Secretary of Commerce;
                            (iii) the Secretary of Defense;
                            (iv) the Secretary of Health and Human 
                        Services;
                            (v) the Secretary of Homeland Security;
                            (vi) the Secretary of Labor;
                            (vii) the Secretary of Transportation;
                            (viii) the Secretary of the Treasury;
                            (ix) the Administrator of the Environmental 
                        Protection Agency;
                            (x) the Administrator of the Federal 
                        Emergency Management Agency;
                            (xi) the Federal Trade Commission;
                            (xii) the Administrator of the Small 
                        Business Administration; and
                            (xiii) the United States Trade 
                        Representative;
                    (B) persons or private sector entities that 
                transport products by air, water, rail, and road;
                    (C) manufacturers of durable consumer products;
                    (D) producers of agricultural products;
                    (E) manufacturers and distributors of drugs, 
                devices, and other medical products and supplies; and
                    (F) manufacturers, producers, and distributors of 
                other supplies critical to national security and the 
                COVID-19 pandemic;
            (3) serve as a central point of contact for Federal and 
        non-Federal entities seeking technical assistance with respect 
        to supply chain issues related to the COVID-19 pandemic;
            (4) provide technical assistance to Federal and non-Federal 
        entities seeking technical assistance with respect to supply 
        chain issues related to the COVID-19 pandemic; and
            (5) develop legislative recommendations to strengthen 
        critical supply chains for pandemics, including the COVID-19 
        pandemic.
    (e) Report to Congress.--Not later than 180 days after the date of 
the enactment of this Act, the Director shall submit a report to 
Congress on--
            (1) any supply chain issues identified under paragraph (1) 
        of subsection (d);
            (2) the national strategy established under such 
        subsection; and
            (3) any legislative recommendation developed under such 
        subsection.
    (f) Termination.--The Office established under this section shall 
terminate on the date that is 18 months after the date on which the 
Public Health Emergency declared by the Secretary of Health and Human 
Services under section 319 of the Public Health Services Act (42 U.S.C. 
247) as a result of COVID-19 pandemic, and any renewal thereof, 
terminates.
                                 <all>